111 (YI) Return on Sales (2017 - 2025)

111 (YI) posted Return on Sales of 0.0% for Q4 2025, down 379.71% sequentially from 0.0% in Q3 2025, and little changed YoY from 0.0% in Q4 2024.

111 (YI) Return on Sales (2017 - 2025) Analysis & Trends

111 has reported Return on Sales for 9 years, with the latest figure at 0.0% in Q4 2025.

Quarterly Return on Sales changed 0.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
Return on Sales retreated to 0.0% in Q4 2025 per YI's latest filing, from 0.0% in the prior quarter.
Over five years, Return on Sales peaked at 0.0% in Q3 2025 and troughed at 0.0% in Q1 2021.
A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Sales.
The widest YoY moves for Return on Sales: up 0 bps in 2021, down 0 bps in 2021.
Over 5 years, Return on Sales stood at 0.0% in 2021, then advanced by 15 bps to 0.0% in 2022, then sank by 99 bps to 0.0% in 2023, then surged by 93 bps to 0.0% in 2024, then rose by 29 bps to 0.0% in 2025.
According to Business Quant data, Return on Sales over the past three periods registered 0.0%, 0.0%, and 0.0% for Q4 2025, Q3 2025, and Q2 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROS (Qtr)
1	Mckesson	102.93 Bn	97.76 Bn	3.69 Bn	0.00%
2	Cencora	61.41 Bn	58.59 Bn	3.61 Bn	0.00%
3	Cardinal Health	54.16 Bn	49.31 Bn	2.56 Bn	0.00%
4	Henry Schein	10.01 Bn	9.85 Bn	1.10 Bn	0.00%
5	Akso Health	679.34 Mn	679.14 Mn	-	-
6	Edap Tms	154.99 Mn	133.45 Mn	7.34 Mn	-0.01%
7	Accendra Health	90.88 Mn	83.23 Mn	263.41 Mn	0.00%
8	111	30.17 Mn	-28.59 Mn	18.18 Mn	0.00%
9	Cosmos Health	13.20 Mn	10.75 Mn	1.51 Mn	0.00%
10	VitaNova Life Sciences	11.51 Mn	9.91 Mn	264,662.00	0.00%

Download Data